NDRA - エンドラ・ライフ・サイエンシズ (ENDRA Life Sciences Inc.)

NDRAのニュース

   ENDRA Life Sciences to Report First Quarter 2022 Financial Results on May 12, 2022  2022/05/02 12:00:00 Business Wire
ANN ARBOR, Mich.--(BUSINESS WIRE)---- $NDRA #NAFLD--ENDRA Life Sciences Inc. (ENDRA) (NASDAQ: NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the first quarter of 2022 on Thursday, May 12, 2022 after the close of trading on the U.S. financial markets. Management will host a conference call and webcast beginning at 4:30 p.m. Eastern time to discuss the results, provide an update on recent corporate developments and answer questions. Partici
   ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option  2022/04/22 12:00:00 Stocks Register
ENDRA Life Sciences Inc. (NASDAQ:NDRA) shares, rose in value on Thursday, April 21, with the stock price up by 1.59% to the previous day’s close as strong demand from buyers drove the stock to $0.27. Actively observing the price movement in the last trading, the stock closed the session at $0.26, falling within a range … ENDRA Life Sciences Inc. (NASDAQ: NDRA) Stock Seems Like A Good Option Read More »
   Endra Life Sciences raises $8.7M YTD from common stock sale through ATM equity facility  2022/04/21 13:08:17 Seeking Alpha
Endra Life Sciences raised $8.7M year-to-date from the sale of common stock through its at the market, or ATM, equity facility.
   Thinking about buying stock in ENDRA Life Sciences, SeaChange, Protalix Biotherapeutics, Dingdong, or BigBear.ai?  2022/04/08 13:31:00 Benzinga
NEW YORK , April 8, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NDRA, SEAC, PLX, DDL, and BBAI. … Full story available on Benzinga.com
   16 Stocks Moving in Friday''s Pre-Market Session  2022/04/08 11:11:38 Benzinga
Gainers Biofrontera Inc. (NASDAQ: BFRI ) rose 34.5% to $5.44 in pre-market trading. ENDRA Life Sciences Inc. (NASDAQ: NDRA ) rose 31.9% to $0.5891 in pre-market trading after gaining over 10% on Thursday. HC Wainwright & Co. maintained ENDRA Life Sciences with a Buy and lowered the price target from $6 to $5. MedAvail Holdings, Inc. (NASDAQ: MDVL ) rose 29.1% to $1.82 in pre-market trading. MedAvail shares jumped 64% on Thursday after Ally Bridge Group reported in a Form4 filing a purchase of roughly 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share. Sunshine Biopharma, Inc. (NASDAQ: SBFM ) shares rose 20.7% to $11.65 in pre-market trading after surging 53% on Thursday. Aterian, Inc. (NASDAQ: … Full story available on Benzinga.com
   ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting  2021/04/08 12:30:00 Yahoo Finance
ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the Company's Chief Technology Officer will be making a presentation at the American Institute of Ultrasound in Medicine (AIUM) Annual Integrative Ultrasound Meeting on April 14 at 11:45 am ET.
   The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs  2021/03/19 11:46:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Vericel Corporation (NASDAQ: VCEL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 18) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) (issued a corporate update) Galecto, Inc. (NASDAQ: GLTO ) Voyager Therapeutics, Inc. (NASDAQ: VYGR ) Stocks In Focus Sarepta Presents Positive Data For Gene Therapy to Treat Limb-gridle Muscular Dystrophy Sarepta Therapeutics, Inc. (NASDAQ: SRPT ) announced new results from the ongoing study of SRP-9003, its investigational gene therapy for limb-girdle muscular dystrophy Type 2E, showing sustained protein expression in muscle tissue.
   ENDRA Life Sciences and Hepion Pharmaceuticals Partner to Drive Efficiencies in NASH Clinical Trials  2021/03/18 08:01:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland  2021/02/17 13:00:00 Yahoo Finance
Study to Bolster Clinical Performance Evidence of TAEUS® Ultrasound Device in NAFLD Patients as Commercialization BeginsANN ARBOR, MI / ACCESSWIRE / February 17, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound .
   The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement  2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.
   ENDRA Life Sciences to Present at AIUM Annual Integrative Ultrasound Meeting  2021/04/08 12:30:00 Yahoo Finance
ANN ARBOR, MI / ACCESSWIRE / April 8, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), today announced that the Company's Chief Technology Officer will be making a presentation at the American Institute of Ultrasound in Medicine (AIUM) Annual Integrative Ultrasound Meeting on April 14 at 11:45 am ET.
   The Daily Biotech Pulse: Sarepta Gene Therapy Data, Idera Plunges On Failed Skin Cancer Study, 3 IPOs  2021/03/19 11:46:46 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 18) AngioDynamics, Inc. (NASDAQ: ANGO ) Anixa Biosciences, Inc. (NASDAQ: ANIX ) ENDRA Life Sciences Inc. (NASDAQ: NDRA ) (announced a collaboration with Hepion Pharmaceuticals, Inc. (NASDAQ: HEPA ) for NASH studies) Harvard Bioscience, Inc. (NASDAQ: HBIO ) Neos Therapeutics, Inc. (NASDAQ: NEOS ) (reacted to the shareholder meeting held to vote on the proposal to merge with Aytu BioScience, Inc. (NASDAQ: AYTU )) NuVasive, Inc. (NASDAQ: NUVA ) SI-BONE, Inc. (NASDAQ: SIBN ) Sierra Oncology, Inc. (NASDAQ: SRRA ) Silverback Therapeutics, Inc. (NASDAQ: SBTX ) Terns Pharmaceuticals, Inc. (NASDAQ: TERN ) Varian Medical Systems, Inc. (NASDAQ: VAR ) Vericel Corporation (NASDAQ: VCEL ) Vincerx Pharma, Inc. (NASDAQ: VINC ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows March 18) Foghorn Therapeutics Inc. (NASDAQ: FHTX ) (issued a corporate update) Galecto, Inc. (NASDAQ: GLTO ) Voyager Therapeutics, Inc. (NASDAQ: VYGR ) Stocks In Focus Sarepta Presents Positive Data For Gene Therapy to Treat Limb-gridle Muscular Dystrophy Sarepta Therapeutics, Inc. (NASDAQ: SRPT ) announced new results from the ongoing study of SRP-9003, its investigational gene therapy for limb-girdle muscular dystrophy Type 2E, showing sustained protein expression in muscle tissue.
   ENDRA Life Sciences and Hepion Pharmaceuticals Partner to Drive Efficiencies in NASH Clinical Trials  2021/03/18 08:01:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   ENDRA Life Sciences Announces New Clinical Study Partnership with Inselspital University Hospital in Bern, Switzerland  2021/02/17 13:00:00 Yahoo Finance
Study to Bolster Clinical Performance Evidence of TAEUS® Ultrasound Device in NAFLD Patients as Commercialization BeginsANN ARBOR, MI / ACCESSWIRE / February 17, 2021 / ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound .
   The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement  2021/01/27 12:35:59 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 26) Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Aslan Pharmaceuticals Ltd (NASDAQ: ASLN ) (reacted to new preclinical data showing its investigational asset ASLAN003 have the lowest potential for hepatotoxicity) BIOLASE Inc (NASDAQ: BIOL ) (reacted to its preliminary fourth-quarter results) BioNano Genomics Inc (NASDAQ: BNGO ) CASI Pharmaceuticals Inc (NASDAQ: CASI ) Cassava Sciences Inc (NASDAQ: SAVA ) Clearpoint Neuro Inc (NASDAQ: CLPT ) Cleveland BioLabs, Inc. (NASDAQ: CBLI ) DarioHealth Corp (NASDAQ: DRIO ) DermTech Inc (NASDAQ: DMTK ) Eli Lilly And Co (NYSE: LLY ) (reacted to positive data for its monoclonal antibody cocktail in treating COVID-19) ENDRA Life Sciences Inc (NASDAQ: NDRA ) ESSA Pharma Inc (NASDAQ: EPIX ) Evelo Biosciences Inc (NASDAQ: EVLO ) Evogene Ltd (NASDAQ: EVGN ) GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH ) Illumina, Inc.

calendar